Medicine of the future

#1
Did you know that scientists have long proven the brain damage in criminals?
1524409875394.png




We could find such damage and prove that a person is asocial.

This isn’t a joke; neural technologies have long been capable of doing this.

But, perhaps, medicine is one of the most important directions of such a sector. After all, the number of people suffering from neurological diseases is growing from year to year and may reach 135.5 million patients around the world by 2050!

But the neural interface technologies will not allow such predictions to come true.

For example, scientists in Italy conducted successful experiments that returned sensations to people on the basis of the Rochester Medical Center.

Studies in monkeys have proven that the neural stimulation of the brain regions responsible for motor functions can initiate the necessary movement and is able to replace the signals of the sense organs: hearing, sight and tactile sensations.

Do you remember the story in the movie “The Notebook”? Perhaps everything wouldn’t have been so tragic if neural interface technologies had been sufficiently developed.

Many universities have been funded to study the impact of neural stimulation on various diseases: dementia, Alzheimer’s, etc. One popular method of non-invasive transcranial direct-current brain stimulation (TDCS) improves memory in patients with these diseases. This stimulation can make neurons work intensively for a long time. In this case, side effects rarely appear, often just passing headaches, or there are none at all.

But that’s not all. Did you know that there are about 190 million people with disabilities in the world, and limited mobility is in the first place? Neural interface technologies will allow people to more comfortably move and exist in society, as well as speed up the rehabilitation process.

All this seems abstract. Basis Neuro will help us believe in this.

Basis Neuro is a public platform for developers, which allows the integration of a neural interface into any product, including any medical development.

Basis Neuro technologies can:

• Significantly reduce the rehabilitation time for patients who suffered a stroke due to the use of neural control and VR technologies;

• Expand the capacities of fully or partially immobilized patients;

• Eliminate the problem of monitoring the condition of patients who require constant care and monitoring;

• Improve the positive dynamics in patients with cognitive impairment;

• Make a multitude of services and technologies accessible to people with visual and hearing impairments;

• Supplement the work of psychologists and psychotherapists with an understanding of what a person really feels and experiences.

The market of neural applications and devices for medicine is estimated to reach $50.5 bln in five years, and this indicates the prospects of this direction.

Due to this, the project team is launching the ICO. A total of __ tokens will be coined, which will provide investors with the following benefits:

· The investor will not only be first to test these technologies, but also receive a discount for obtaining the SDK and neural interface license (30% closed Pre Sale, 20% open presale, 10% ICO)

· When investing from $10,000 at the PRESALE stage, the investor receives WhiteLabel (it will cost several times more if obtained later)

· The investor can become a strategic partner (in case of significant investment), and they are provided with priority consulting on the implementation of developments and participation in the expert council of the innovation fund.

The number of licenses a developer can get ultimately depends on the number of tokens. The creation of each product requires a new license, which means it is better to buy tokens at a lower price during the ICO.

Neural interfaces in medicine are a new, promising and very important decision in healthcare.

You can find more information, apply for whitelist or contact the team here:

www.ico.basisneuro.com